Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|July 23, 2003
Combination therapy: appropriate for everyone?George Bensch, Bruce M Prenner
Journal of Asthma and Allergy|July 29, 2016
A review of the clinical efficacy and safety of MP-AzeFlu, a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate, in clinical studies conducted during different allergy seasons in the USBruce M Prenner
Current Opinion in Pulmonary Medicine|November 29, 2007
Role of long-acting beta2-adrenergic agonists in asthma management based on updated asthma guidelinesBruce M Prenner
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|July 10, 2008
Asthma 2008: targeting immunoglobulin E to achieve disease controlBruce M Prenner
Expert Opinion on Pharmacotherapy|November 16, 2007
Formoterol dry-powder inhaler for the treatment of asthma and chronic obstructive pulmonary diseaseBruce M Prenner
The American Journal of Medicine|February 24, 2006
Allergic rhinitis: treatment based on patient profilesBruce M Prenner, Eric Schenkel
Allergy and Asthma Proceedings|June 29, 2011
Safety of fixed-dose loratadine/montelukast in subjects with allergic rhinitisBruce M Prenner, Susan Lu, Melvyn R Danzig
The Journal of Allergy and Clinical Immunology|March 19, 2003
Efficacy and safety of desloratadine in the treatment of perennial allergic rhinitisF Estelle R Simons, Bruce M Prenner, Albert Finn, et al.
Clinical Therapeutics|April 16, 2002
Randomized, double-masked, placebo-controlled comparison of the efficacy of emedastine difumarate 0.05% ophthalmic solution and ketotifen fumarate 0.025% ophthalmic solution in the human conjunctival allergen challenge modelPeter A D'Arienzo, Andrea Leonardi, George Bensch
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|April 10, 2012
A randomized, double-blind, placebo-controlled study assessing the safety and tolerability of regadenoson in subjects with asthma or chronic obstructive pulmonary diseaseBruce M Prenner, Stan Bukofzer, Sarah Behm, et al.
Pageof 3